<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>MARCH5-MFN2 axis &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/march5-mfn2-axis/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 11 Nov 2025 11:46:51 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>MARCH5-MFN2 axis &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Enhancing Mitochondrial Fusion to Combat Multiple Myeloma</title>
		<link>https://bioengineer.org/enhancing-mitochondrial-fusion-to-combat-multiple-myeloma/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 11 Nov 2025 11:46:33 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[cancer drug resistance]]></category>
		<category><![CDATA[MARCH5-MFN2 axis]]></category>
		<category><![CDATA[mitochondrial fusion]]></category>
		<category><![CDATA[Multiple myeloma treatment]]></category>
		<category><![CDATA[venetoclax therapy]]></category>
		<guid isPermaLink="false">https://bioengineer.org/enhancing-mitochondrial-fusion-to-combat-multiple-myeloma/</guid>

					<description><![CDATA[In the realm of cancer therapy, particularly in the treatment of multiple myeloma, researchers have recently focused their efforts on exploiting the intricate pathways that govern mitochondrial function. The recent study by Valentino et al. sheds light on the MARCH5-MFN2 axis, revealing how targeted manipulation of this pathway can enhance mitochondrial fusion and potentially revolutionize [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">294702</post-id>	</item>
	</channel>
</rss>
